Document:

Form of Stock Option Agreement under the 2009 Plan

 Exhibit 10.6.1 
 Option No.                      
 MYRIAD PHARMACEUTICALS, INC. 
 Stock Option Grant Notice 
 Stock Option Grant under the Company’s 
 2009 Employee, Director and Consultant Equity Incentive Plan 
  

			
	 1.        Name and Address of Participant:
	 	  

		 	  

		 	  

		
	 2.        Date of Option Grant:
	 	  

		
	 3.        Type of Grant:
	 	  

		
	 4.        Maximum Number of Shares for which this Option is   exercisable:
	 	  

		
	 5.        Exercise (purchase) price per share:
	 	  

		
	 6.        Option Expiration Date:
	 	  

		
	 7.        Vesting Start Date:
	 	  

	
	 8.        Vesting Schedule: This Option shall become exercisable (and the Shares issued
upon exercise shall be vested) as follows   provided the Participant is an employee, director or Consultant of the Company or of an Affiliate on the applicable vesting   date:

 [Insert Vesting Schedule - sample below] 
  

					
	 [On the first anniversary of the Vesting Start Date
	    	up to              Shares	  	
			
	 On the second anniversary of the Vesting Start Date
	    	an additional              Shares	  	
			
	 On the third anniversary of the Vesting Start Date
	    	an additional              Shares]	  	

 [Notwithstanding the foregoing, in the event of a Change of Control (as defined in the Plan),
    % of the Shares which would have vested in each vesting installment remaining under this Option will be vested for purposes of Section 24(b) of the Plan unless this Option has otherwise expired or been terminated
pursuant to its terms or the terms of the Plan.] 

 The foregoing rights are cumulative and are subject to the other terms and conditions of this Agreement
and the Plan. 
 The Company and the Participant acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock
Option Agreement attached hereto and incorporated by reference herein, the Company’s 2009 Employee, Director and Consultant Equity Incentive Plan and the terms of this Option Grant as set forth above. 
  

			
	MYRIAD PHARMACEUTICALS, INC.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

			
	  

	Participant	 	

  

 2 

 MYRIAD PHARMACEUTICALS, INC. 
 STOCK OPTION AGREEMENT - INCORPORATED TERMS AND CONDITIONS 
 AGREEMENT
made as of the date of grant set forth in the Stock Option Grant Notice between Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and the individual whose name appears on the Stock Option Grant Notice (the
“Participant”). 
 WHEREAS, the Company desires to grant to the Participant an Option to purchase shares of its common stock, $0.01
par value per share (the “Shares”), under and for the purposes set forth in the Company’s 2009 Employee, Director and Consultant Equity Incentive Plan (the “Plan”); 
 WHEREAS, the Company and the Participant understand and agree that any terms used and not defined herein have the same meanings as in the Plan; and

 WHEREAS, the Company and the Participant each intend that the Option granted herein shall be of the type set forth in the Stock Option
Grant Notice. 
 NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable
consideration, the parties hereto agree as follows: 
 1. GRANT OF OPTION. 
 The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares set forth in the
Stock Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein, under United States securities and tax laws, and in the Plan, which is incorporated herein by reference. The Participant acknowledges receipt
of a copy of the Plan. 
 2. EXERCISE PRICE. 
 The exercise price of the Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to adjustment, as provided in the Plan, in the event of a stock split, reverse
stock split or other events affecting the holders of Shares after the date hereof (the “Exercise Price”). Payment shall be made in accordance with Paragraph 9 of the Plan. 
 3. EXERCISABILITY OF OPTION. 
 Subject
to the terms and conditions set forth in this Agreement and the Plan, the Option granted hereby shall become exercisable as set forth in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement and the Plan.

 4. TERM OF OPTION. 
 This Option shall terminate ten years from the date of this Agreement or, if this Option is designated in the Stock Option Grant Notice as an ISO and the Participant owns as of the date hereof more than 10% of the
total combined voting power of all classes of capital stock of the Company or an Affiliate, five years from the date of this Agreement, but shall be subject to earlier termination as provided herein or in the Plan. 
 If the Participant ceases to be an employee, director or Consultant of the Company or of an Affiliate for any reason other than the death or Disability
of the Participant, or termination of the Participant for Cause, the Option may be exercised, if it has not previously terminated, within three months after the date the Participant ceases to provide service to the Company or an Affiliate, or within
the originally prescribed term of the Option, whichever is earlier, but may not be exercised thereafter except as set forth below. In such event, the Option shall be exercisable only to the extent that the Option has become exercisable and is in
effect at the date of such cessation of service. 
 If this Option is designated in the Stock Option Grant Notice as an ISO and the
Participant ceases to be an employee of the Company or of an Affiliate but continues after termination of employment to provide service to the Company or an Affiliate as a director or Consultant, this Option shall continue to vest in accordance with
Section 3 above as if this Option had not terminated until the Participant is no longer providing services to the Company. In such case, this Option shall automatically convert and be deemed a Non-Qualified Option as of the date that is three
months from termination of the Participant’s employment and this Option shall continue on the same terms and conditions set forth herein until such Participant is no longer providing service to the Company or an Affiliate. 
 Notwithstanding the foregoing, in the event of the Participant’s Disability or death within three months after the termination of service, the
Participant or the Participant’s Survivors may exercise the Option within one year after the date of the Participant’s termination of service, but in no event after the date of expiration of the term of the Option. 
 In the event the Participant’s service is terminated by the Company or an Affiliate for Cause, the Participant’s right to exercise any
unexercised portion of this Option shall cease immediately as of the time the Participant is notified his or her service is terminated for Cause, and this Option shall thereupon terminate. Notwithstanding anything herein to the contrary, if
subsequent to the Participant’s termination, but prior to the exercise of the Option, the Board of Directors of the Company determines that, either prior or subsequent to the Participant’s termination, the Participant engaged in conduct
which would constitute Cause, then the Participant shall immediately cease to have any right to exercise the Option and this Option shall thereupon terminate. 
 In the event of the Disability of the Participant, as determined in accordance with the Plan, the Option shall be exercisable within one year after the Participant’s termination of service or, if earlier, within
the term originally prescribed by the Option. In such event, the Option shall be exercisable: 
  

	 	(a)	to the extent that the Option has become exercisable but has not been exercised as of the date of Disability; and 

  

 2 

	 	(b)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of Disability of any additional vesting rights that would have
accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date of Disability. 

 In the event of the death of the Participant while an employee, director or Consultant of the Company or of an Affiliate, the Option shall be exercisable
by the Participant’s Survivors within one year after the date of death of the Participant or, if earlier, within the originally prescribed term of the Option. In such event, the Option shall be exercisable: 
  

	 	(x)	to the extent that the Option has become exercisable but has not been exercised as of the date of death; and 

  

	 	(y)	in the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of death of any additional vesting rights that would have
accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant’s date of death. 

 5. METHOD OF EXERCISING OPTION. 
 Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in substantially the form of Exhibit A attached hereto. Such notice shall state the number of
Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option. Payment of the Exercise Price for such Shares shall be made in accordance with Paragraph 9 of the Plan. The Company shall deliver
such Shares as soon as practicable after the notice shall be received, provided, however, that the Company may delay issuance of such Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any
applicable law (including, without limitation, state securities or “blue sky” laws). The Shares as to which the Option shall have been so exercised shall be registered in the Company’s share register in the name of the person so
exercising the Option (or, if the Option shall be exercised by the Participant and if the Participant shall so request in the notice exercising the Option, shall be registered in the Company’s share register in the name of the Participant and
another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written order of the person exercising the Option. In the event the Option shall be exercised, pursuant to Section 4 hereof, by any
person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully paid
and nonassessable. 
  

 3 

 6. PARTIAL EXERCISE. 
 Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except that no fractional share shall be issued pursuant to this Option. 
 7. NON-ASSIGNABILITY. 
 The Option
shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution. If this Option is a Non-Qualified Option then it may also be transferred pursuant to a qualified domestic relations order as defined by
the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder and the Participant, with the approval of the Administrator, may transfer the Option for no consideration to or for the benefit of the Participant’s
Immediate Family (including, without limitation, to a trust for the benefit of the Participant’s Immediate Family or to a partnership or limited liability company for one or more members of the Participant’s Immediate Family), subject to
such limits as the Administrator may establish, and the transferee shall remain subject to all the terms and conditions applicable to the Option prior to such transfer and each such transferee shall so acknowledge in writing as a condition precedent
to the effectiveness of such transfer. The term “Immediate Family” shall mean the Participant’s spouse, former spouse, parents, children, stepchildren, adoptive relationships, sisters, brothers, nieces, nephews and grandchildren (and,
for this purpose, shall also include the Participant). Except as provided above in this paragraph, the Option shall be exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of legal incapacity or
incompetency, by the Participant’s guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any
attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 7, or the levy of any attachment or similar process upon the Option shall be
null and void. 
 8. NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE. 
 The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares in the
Company’s share register in the name of the Participant. Except as is expressly provided in the Plan with respect to certain changes in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for which the
record date is prior to the date of such registration. 
 9. ADJUSTMENTS. 
 The Plan contains provisions covering the treatment of Options in a number of contingencies such as stock splits and mergers. Provisions in the Plan for
adjustment with respect to stock subject to Options and the related provisions with respect to successors to the business of the Company are hereby made applicable hereunder and are incorporated herein by reference. 
  

 4 

 10. TAXES. 
 The Participant acknowledges that any income or other taxes due from him or her with respect to this Option or the Shares issuable pursuant to this Option shall be the Participant’s responsibility. The
Participant acknowledges and agrees that (i) the Participant was free to use professional advisors of his or her choice in connection with this Agreement, has received advice from his or her professional advisors in connection with this
Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress; (ii) the Participant has not received and is not relying upon any advice, representations or assurances made by or on
behalf of the Company or any Affiliate or any employee of or counsel to the Company or any Affiliate regarding any tax or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement and (iii) neither
the Company its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the Option constitutes
deferred compensation under Section 409A of the Code. 
 If this Option is designated in the Stock Option Grant Notice as an ISO and
there is a Disqualifying Disposition (as defined in Section 15 below) or if the Option is converted into a Non-Qualified Option and such Non-Qualified Option is exercised, the Participant agrees that the Company may withhold from the
Participant’s remuneration, if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation includable in such person’s gross income. At the Company’s
discretion, the amount required to be withheld may be withheld in cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option. The Participant further agrees that, if the Company does
not withhold an amount from the Participant’s remuneration sufficient to satisfy the Company’s income tax withholding obligation, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld. 
 11. PURCHASE FOR INVESTMENT. 
 Unless
the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under the Securities Act of 1933, as now in force or hereafter amended (the “1933 Act”), the Company shall
be under no obligation to issue the Shares covered by such exercise unless and until the following conditions have been fulfilled: 
  

	 	(a)	The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective accounts,
for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound by the provisions of the following legend which shall be endorsed upon any
certificate(s) evidencing the Shares issued pursuant to such exercise: 

  

 5 

 “The shares represented by this certificate have been taken for investment and they may not be sold
or otherwise transferred by any person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b) the Company shall have
received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable state securities laws;” and 
  

	 	(b)	If the Company so requires, the Company shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance with the 1933 Act
without registration thereunder. Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law
(including without limitation state securities or “blue sky” laws). 

 12. RESTRICTIONS ON TRANSFER OF SHARES.

 12.1 The Participant agrees that in the event the Company proposes to offer for sale to the public any of its equity securities and such
Participant is requested by the Company and any underwriter engaged by the Company in connection with such offering to sign an agreement restricting the sale or other transfer of Shares, then it will promptly sign such agreement and will not
transfer, whether in privately negotiated transactions or to the public in open market transactions or otherwise, any Shares or other securities of the Company held by him or her during such period as is determined by the Company and the
underwriters, not to exceed 180 days following the closing of the offering, plus such additional period of time as may be required to comply with Marketplace Rule 2711 of the National Association of Securities Dealers, Inc. or similar rules thereto
(such period, the “Lock-Up Period”). Such agreement shall be in writing and in form and substance reasonably satisfactory to the Company and such underwriter and pursuant to customary and prevailing terms and conditions. Notwithstanding
whether the Participant has signed such an agreement, the Company may impose stop-transfer instructions with respect to the Shares or other securities of the Company subject to the foregoing restrictions until the end of the Lock-Up Period.

 12.2 The Participant acknowledges and agrees that neither the Company, its shareholders nor its directors and officers, has any duty or
obligation to disclose to the Participant any material information regarding the business of the Company or affecting the value of the Shares before, at the time of, or following a termination of the service of the Participant by the Company,
including, without limitation, any information concerning plans for the Company to make a public offering of its securities or to be acquired by or merged with or into another firm or entity. 
  

 6 

 13. NO OBLIGATION TO MAINTAIN RELATIONSHIP. 
 The Company is not by the Plan or this Option obligated to continue the Participant as an employee, director or Consultant of the Company or an Affiliate.
The Participant acknowledges: (i) that the Plan is discretionary in nature and may be suspended or terminated by the Company at any time; (ii) that the grant of the Option is a one-time benefit which does not create any contractual or
other right to receive future grants of options, or benefits in lieu of options; (iii) that all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the number of shares
subject to each option, the option price, and the time or times when each option shall be exercisable, will be at the sole discretion of the Company; (iv) that the Participant’s participation in the Plan is voluntary; (v) that the
value of the Option is an extraordinary item of compensation which is outside the scope of the Participant’s employment or consulting contract, if any; and (vi) that the Option is not part of normal or expected compensation for purposes of
calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 
 14. IF OPTION IS INTENDED TO BE AN ISO. 
 If this Option is designated in the Stock Option Grant
Notice as an ISO so that the Participant (or the Participant’s Survivors) may qualify for the favorable tax treatment provided to holders of Options that meet the standards of Section 422 of the Code, then any provision of this Agreement
or the Plan which conflicts with the Code so that this Option would not be deemed an ISO is null and void and any ambiguities shall be resolved so that the Option qualifies as an ISO. Nonetheless, if the Option is determined not to be an ISO, the
Participant understands that neither the Company nor any Affiliate is responsible to compensate him or her or otherwise make up for the treatment of the Option as a Non-Qualified Option and not as an ISO. The Participant should consult with the
Participant’s own tax advisors regarding the tax effects of the Option and the requirements necessary to obtain favorable tax treatment under Section 422 of the Code, including, but not limited to, holding period requirements. 

Notwithstanding the foregoing, to the extent that the Option is designated in the Stock Option Grant Notice as an ISO and is not deemed to be an ISO
pursuant to Section 422(d) of the Code because the aggregate fair market value (determined as of the date hereof) of any of the Shares with respect to which this ISO is granted becomes exercisable for the first time during any calendar year in
excess of $100,000, the portion of the Option representing such excess value shall be treated as a Non-Qualified Option and the Participant shall be deemed to have taxable income measured by the difference between the then fair market value of the
Shares received upon exercise and the price paid for such Shares pursuant to this Agreement. 
 15. NOTICE TO COMPANY OF DISQUALIFYING
DISPOSITION OF AN ISO. 
 If this Option is designated in the Stock Option Grant Notice as an ISO then the Participant agrees to notify
the Company in writing immediately after the Participant makes a Disqualifying Disposition of any of the Shares acquired pursuant to the exercise of the ISO. A Disqualifying Disposition is defined in Section 424(c) of the Code and includes any
disposition (including any sale) of 

  

 7 

 
such Shares before the later of (a) two years after the date the Participant was granted the ISO or (b) one year after the date the Participant
acquired Shares by exercising the ISO, except as otherwise provided in Section 424(c) of the Code. If the Participant has died before the Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur
thereafter. 
 16. NOTICES. 
 Any notices required or permitted by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows: 
 If to the Company: 
 Myriad Pharmaceuticals, Inc. 

         Chipeta Way 
 Salt Lake City, UT 84108 
 Attention:

 If to the Participant at the address set forth on the Stock Option Grant Notice 
 or to such other address or addresses of which notice in the same manner has previously been given. Any such notice shall be deemed to have been given upon the earlier of receipt, one business day following delivery
to a recognized courier service or three business days following mailing by registered or certified mail. 
 17. GOVERNING LAW.

 This Agreement shall be construed and enforced in accordance with the law of the Delaware, without giving effect to the conflict of
law principles thereof. For the purpose of litigating any dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in Utah and agree that such litigation shall be conducted in the state courts of Salt Lake City,
Utah or the federal courts of the United States for the District of Utah. 
 18. BENEFIT OF AGREEMENT. 
 Subject to the provisions of the Plan and the other provisions hereof, this Agreement shall be for the benefit of and shall be binding upon the heirs,
executors, administrators, successors and assigns of the parties hereto. 
 19. ENTIRE AGREEMENT. 
 This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter
hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to
interpret, change or restrict, the express terms and provisions of this Agreement, provided, however, in any event, this Agreement shall be subject to and governed by the Plan. 
  

 8 

 20. MODIFICATIONS AND AMENDMENTS. 
 The terms and provisions of this Agreement may be modified or amended as provided in the Plan. 
 21. WAIVERS AND CONSENTS. 
 Except as
provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or
consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the
purpose for which it was given, and shall not constitute a continuing waiver or consent. 
 22. DATA PRIVACY. 
 By entering into this Agreement, the Participant: (i) authorizes the Company and each Affiliate, and any agent of the Company or any Affiliate
administering the Plan or providing Plan recordkeeping services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant of options and the
administration of the Plan; (ii) waives any data privacy rights he or she may have with respect to such information; and (iii) authorizes the Company and each Affiliate to store and transmit such information in electronic form. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 9 

 Exhibit A 
 NOTICE OF EXERCISE OF STOCK OPTION 
 [Form for Employees for Shares registered in the United
States] 
 To:    Myriad Pharmaceuticals, Inc. 
 IMPORTANT NOTICE: This form of Notice of Exercise may only be used at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of the Shares for which this exercise is
being made is registered and such Registration Statement remains effective. 
 Ladies and Gentlemen: 
 I hereby exercise my Stock Option to purchase          shares (the “Shares”) of the common
stock, $0.01 par value, of Myriad Pharmaceuticals, Inc. (the “Company”), at the exercise price of $         per share, pursuant to and subject to the terms of that Stock Option Grant Notice
dated             , 200  . 
 I understand the nature of
the investment I am making and the financial risks thereof. I am aware that it is my responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the
exercise of the Option and the purchase and subsequent sale of the Shares. 
 I am paying the option exercise price for the Shares as
follows: 
                                        
                                      
 Please issue the Shares (check one): 
  ̈  to me; or 
  ̈  to me and
                                        ,
as joint tenants with right of survivorship, 
 at the following address: 
  

			
		 	  

	 	 	  

		 	  

  

 Exhibit A-1 

 My mailing address for shareholder communications, if different from the address listed above, is:

  

			
		 	  

	 	 	  

		 	  

  

	
	Very truly yours,
	
	  

	Participant (signature)
	
	  

	Print Name
	
	  

	Date
	
	  

	Social Security Number

  

 Exhibit A-2Form of Restricted Stock Unit Agreement under the 2009 Plan

 Exhibit 10.6.2 
 RESTRICTED STOCK UNIT AGREEMENT 
 Myriad Pharmaceuticals, Inc. 
 AGREEMENT made as of the      day of         , 2009 (the “Grant
Date”), between Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and
[                                       
 ] (the “Participant”). 
 WHEREAS, the Company has adopted the Myriad Pharmaceuticals, Inc. 2009 Employee, Director and
Consultant Equity Incentive Plan (the “Plan”), to promote the interests of the Company by providing an incentive for employees, directors and consultants of the Company, its Parent and its Subsidiaries; 
 WHEREAS, pursuant to the provisions of the Plan, the Company desires to grant to the Participant restricted stock units (“RSUs”) related to the
Company’s common stock, $0.01 par value per share (“Common Stock”), in accordance with the provisions of the Plan, all on the terms and conditions hereinafter set forth; and 
 WHEREAS, the Company and the Participant understand and agree that any terms used and not defined herein have the meanings ascribed to such terms in the
Plan. 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows: 
 1. Grant of
Award. The Company hereby grants to the Participant an aggregate of                      RSUs (the “Award”) which represents a
contingent entitlement of the Participant to receive shares of Common Stock, on the terms and conditions and subject to all the limitations set forth herein and in the Plan, which is incorporated herein by reference. The Participant acknowledges
receipt of a copy of the Plan. 
 2. Vesting of Award. 
 (a) Subject to the terms and conditions set forth in this Agreement and the Plan, the Award granted hereby shall vest as follows provided that the Participant is still an employee, a director or a consultant of the
Company, its Parent or a Subsidiary on the applicable vesting date: 
 [Insert Vesting Schedule -sample below] 
  

			
	 Number of RSUs
	  	Vesting Date
	[50% of the total amount]	  	            , 200  
		
	[50% of the total amount]	  	            , 200  

 [If the vesting is performance based consider: If the Vesting Date has not occurred prior to
                    , then this Award shall expire and this Agreement shall terminate and be of no further force or effect.] 

On each vesting date set forth above, the Participant shall be entitled to receive such number of shares of Common Stock equivalent to the number of
RSUs set forth opposite such vesting date provided that the Participant is employed by the Company, its Parent or a Subsidiary on such vesting date. Such shares of Common Stock shall thereafter be delivered by the Company to the Participant within 5
days of the applicable vesting date and in accordance with this Agreement and the Plan. The purchase price is $0.01 per share payable if and when shares of Common Stock are issued by the Company, which payment will be made by the Company on behalf
of the Participant as compensation for the Participant’s prior service to the Company and which amount will be reported as income on the Participant’s W-2 (or other applicable form) in the year of payment. Notwithstanding 

 
the foregoing, if the Participant is as of the applicable vesting date a “specified employee” (as defined under Section 409A of the Internal
Revenue Code) then such payment of shares of Common Stock, if required by Section 409A of the Code, will be made six months after the date of such Separation from Service (as defined in Section 409A of the Internal Revenue Code).

 (b) Except as otherwise set forth in this Agreement, if the Participant ceases to be employed for any reason by the Company, its Parent or
a Subsidiary (the “Termination”) prior to a vesting date set forth in Section 2(a) above, then as of the date on which the Participant’s employment terminates, all unvested RSUs shall immediately be forfeited to the Company and
this Agreement shall terminate and be of no further force or effect. 
 (c) Effect of a For Cause Termination. Notwithstanding
anything to the contrary contained in this Agreement, in the event the Company, its Parent or a Subsidiary terminates the Participant’s employment or service for Cause, all of the RSUs then held by the Participant shall be forfeited to the
Company immediately as of the time the Participant is notified that he or she has been terminated for Cause or that he or she engaged in conduct which would constitute Cause and this Agreement shall terminate and be of no further force or effect.

 [(d) Effect of Termination for Disability or upon Death. The following rules apply if the Participant’s Termination is by
reason of Disability or death: in addition to any portion of the Award that has become vested as of the date of Disability or death, as case may be, the Participant shall be deemed to have vested to the extent of a pro rata portion of the Award
through the date of Disability or death of any additional vesting rights that would have accrued on the next vesting date had the Participant not become Disabled or died, as the case may be. The proration shall be based upon the number of days
accrued in such current vesting period prior to the Participant’s date of Disability or death, as the case may be.] 
 [(e)
Effect of a Change of Control. Notwithstanding Subsection 2(a) above, the Award granted hereby shall fully vest and the Participant shall be entitled to receive such number of shares of Common Stock equivalent to the number of RSUs which have
been issued pursuant to Section 1 above immediately prior to and on the same day as a Change of Control (as defined in the Plan).] 
 3. Prohibitions on Transfer and Sale. This Award (including any additional RSUs received by the Participant as a result of stock dividends, stock splits or any other similar transaction affecting the Company’s securities without
receipt of consideration) shall not be transferable by the Participant otherwise than (i) by will or by the laws of descent and distribution, or (ii) or pursuant to a qualified domestic relations order as defined by the Internal Revenue
Code or Title I of the Employee Retirement Income Security Act or the rules thereunder. Except as provided in the previous sentence, the shares of Common Stock to be issued pursuant to this Agreement shall be issued, during the Participant’s
lifetime, only to the Participant (or, in the event of legal incapacity or incompetence, to the Participant’s guardian or representative). This Award shall not be assigned, pledged or hypothecated in any way (whether by operation of law or
otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of this Award or of any rights granted hereunder contrary to the provisions of this
Section 3, or the levy of any attachment or similar process upon this Award shall be null and void. 
 4. Adjustments. The Plan
contains provisions covering the treatment of RSUs and shares of Common Stock in a number of contingencies such as stock splits, mergers and upon a Change of Control. Provisions in the Plan for adjustment with respect to this Award and the related
provisions with respect to successors to the business of the Company are hereby made applicable hereunder and are incorporated herein by reference. 
 5. Securities Law Compliance. The Participant specifically acknowledges and agrees that any sales of shares of Common Stock shall be made in accordance with the requirements of the Securities Act of 1933, as amended. The Company
currently has an 

 
effective registration statement on file with the Securities and Exchange Commission with respect to the Common Stock to be granted hereunder. The Company
intends to maintain this registration statement but has no obligation to do so. If the registration statement ceases to be effective for any reason or there is a restriction under foreign law, you will not be able to transfer or sell any of the
shares of Common Stock issued to you pursuant to this Agreement unless exemptions from registration or filings under applicable securities laws are available. The Company shall not be obligated to either issue the Common Stock or permit the resale
of any shares of Common Stock if such issuance or resale would violate any applicable securities law, rule or regulation. 
 6. Rights as
a Stockholder. The Participant shall have no right as a stockholder, including voting and dividend rights, with respect to the RSUs subject to this Agreement. 
 7. Incorporation of the Plan. The Participant specifically understands and agrees that the RSUs and the shares of Common Stock to be issued under the Plan will be issued to the Participant pursuant to the Plan,
a copy of which Plan the Participant acknowledges he or she has read and understands and by which Plan he or she agrees to be bound. The provisions of the Plan are incorporated herein by reference. 
 8. Tax Liability of the Participant and Payment of Taxes. The Participant acknowledges and agrees that any income or other taxes due from
the Participant with respect to this Award or the shares of Common Stock to be issued pursuant to this Agreement or otherwise sold shall be the Participant’s responsibility. Without limiting the foregoing, the Participant agrees that if under
applicable law the Participant will owe taxes at each vesting date on the portion of the Award then vested the Company shall be entitled to immediate payment from the Participant of the amount of any tax required to be withheld by the Company. Any
taxes due shall be paid, at the option of the Company as follows: 
 (a) through reducing the number of shares of Common Stock actually
issued to the Participant on the applicable vesting date in an amount equal to the amount of minimum withholding tax due and payable by the Company. Fractional shares will not be retained to satisfy any portion of the withholding tax. Accordingly,
the Participant agrees that in the event that the amount of withholding owed would result in a fraction of a share being owed, that amount will be satisfied by withholding the fractional amount from the Participant’s paycheck; 
 (b) requiring the Participant to deposit with the Company an amount of cash equal to the amount determined by the Company to be required with respect to
the statutory minimum of the Participant’s estimated total federal, state and local tax obligations or otherwise withholding from the Participant’s paycheck an amount equal to the withholding tax due and payable; or 
 (c) authorizing the sale by the Participant on the applicable vesting date of such number of shares of Common Stock as the Company instructs a registered
broker to sell to satisfy the Company’s withholding obligations, after deduction of the broker’s commission, and the broker shall be required to remit to the Company the cash necessary in order for the Company to satisfy its withholding
obligation. In connection with such sale, the Participant shall execute any such documents requested by broker in order to effectuate the sale of the shares and payment of the withholding obligation to the Company. 
 The Company shall not deliver any shares of Common Stock to the Participant until it is satisfied that all required withholdings have been made.

 9. Participant Acknowledgements and Authorizations. 
 The Participant acknowledges the following: 
 (a) The Company is not by the Plan or this Award obligated to
continue the Participant as an employee, director or consultant of the Company, its Parent or a Subsidiary. 

 (b) The Plan is discretionary in nature and may be suspended or terminated by the Company at any time.

 (c) The grant of this Award is considered a one-time benefit and does not create a contractual or other right to receive any other award
under the Plan, benefits in lieu of awards or any other benefits in the future. 
 (d) The Plan is a voluntary program of the Company and
future awards, if any, will be at the sole discretion of the Company, including, but not limited to, the timing of any grant, the amount of any award, vesting provisions and the purchase price, if any. 
 (e) The value of this Award is an extraordinary item of compensation outside of the scope of any employment. As such the Award is not part of normal or
expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. The future value of the shares of Common Stock is
unknown and cannot be predicted with certainty. 
 (f) The Participant authorizes his or her employer to furnish the Company (and any agent
administering the Plan or providing recordkeeping services) with such information and data as it shall request in order to facilitate the grant of the Award and the administration of the Plan, and the Participant waives any data privacy rights he or
she may have with respect to such information or the sharing of such information. 
 10. Notices. Any notices required or permitted by
the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile, registered or certified mail, return receipt requested, addressed as follows: 
 If to the Company: 
 Myriad Pharmaceuticals,
Inc. 
          Chipeta Way 
 Salt Lake City, UT 84108 
 If to the
Participant: 
  

			
	  
 	 	  
	  
 	 	  
	  
 	 	  

 or to such other address or addresses of which notice in the same manner has previously been given. Any such
notice shall be deemed to have been given on the earliest of receipt, one business day following delivery by the sender to a recognized courier service, or three business days following mailing by registered or certified mail. 
 11. Assignment and Successors. 
 (a)
This Agreement is personal to the Participant and without the prior written consent of the Company shall not be assignable by the Participant otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit
of and be enforceable by the Participant’s legal representatives. 
 (b) This Agreement shall inure to the benefit of and be binding
upon the Company and its successors and assigns. 

 [(c) If this Agreement has not otherwise expired, the Company will require any successor (whether
direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the
Company would be required to perform it if no such succession had taken place. - Note: This provision is NOT necessary if the RSUs vest on a change of control.] 
 12. Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the Delaware, without giving effect to the conflict of law principles thereof. For the purpose of litigating any
dispute that arises under this Agreement, whether at law or in equity, the parties hereby consent to exclusive jurisdiction in the Utah and agree that such litigation shall be conducted in the state courts of Utah or the federal courts of the United
States for the District of Utah. 
 13. Severability. If any provision of this Agreement is held to be invalid or unenforceable by a
court of competent jurisdiction, then such provision or provisions shall be modified to the extent necessary to make such provision valid and enforceable, and to the extent that this is impossible, then such provision shall be deemed to be excised
from this Agreement, and the validity, legality and enforceability of the rest of this Agreement shall not be affected thereby. 
 14.
Entire Agreement. This Agreement, together with the Plan, constitutes the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and
understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect or be used to interpret, change or restrict the express terms and provisions
of this Agreement provided, however, in any event, this Agreement shall be subject to and governed by the Plan. 
 15. Modifications and
Amendments; Waivers and Consents. The terms and provisions of this Agreement may be modified or amended as provided in the Plan. Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the
departure therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms
or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. 
 16. Counterparts. This Agreement may be executed in one or more counterparts, and by different parties hereto on separate counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 17. Data Privacy. By
entering into this Agreement, the Participant: (i) authorizes the Company, its Parent and each Subsidiary, and any agent of the Company, its Parent or any Subsidiary administering the Plan or providing Plan record keeping services, to disclose
to the Company, its Parent or any of its Subsidiaries such information and data as the Company, its Parent or any Subsidiary shall request in order to facilitate the grant of RSUs and the administration of the Plan; (ii) waives any data privacy
rights he or she may have with respect to such information; and (iii) authorizes the Company, its Parent and each Subsidiary to store and transmit such information in electronic form. 
 18. Section 409A. Notwithstanding any other provision of this Agreement to the contrary, the Agreement shall be interpreted and at all times
administered in a manner that avoids the inclusion of compensation in income under Section 409A(a)(1) of the Internal Revenue Code. Any provision inconsistent with Section 409A of the Internal Revenue Code will be read out of the
Agreement. It is intended that each installment of the payments and benefits provided under this Agreement shall be treated as a separate “payment” for purposes of Section 409A of the Internal Revenue Code. Neither the Company nor the
Participant shall have the right to accelerate or defer the delivery of any such payments or benefits except to the extent specifically permitted or required by Section 409A of the Internal Revenue Code. 

 [THE NEXT PAGE IS THE SIGNATURE PAGE] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above
written. 
  

			
	MYRIAD PHARMACEUTICALS, INC.
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	PARTICIPANT:
	
	  

	Print Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00159-of-00352.parquet"}]]